Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis Conference Paper


Authors: Lentzsch, S.; Lagos, G. G.; Comenzo, R. L.; Zonder, J. A.; Pregja, S.; Osman, K.; Tsai, W. Y.; Landau, H.; Sanchorawala, V.
Title: Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis
Conference Title: 16th International Symposium on Amyloidosis
Journal Title Amyloid
Volume: 26
Issue: Suppl. 1
Conference Dates: 2019 Mar 26-29
Conference Location: Kumamoto, Japan
ISBN: 1350-6129
Publisher: Taylor & Francis Group  
Date Published: 2019-01-01
Start Page: 113
End Page: 114
Language: English
DOI: 10.1080/13506129.2019.1583200
PUBMED: 31343313
PROVIDER: scopus
DOI/URL:
Notes: Letter -- Export Date: 4 September 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Heather Jolie Landau
    419 Landau